BCL2 and diffuse large B-cell lymphoma: C3 which was characterized by BCL2 and chromatin modifier mutations, C4 was defined by mutations in four linker and four core histone genes, and these two pathways are mentioned together because they both represent subtypes of GCB type DLBCL (Chapuy et al., 2018).